MAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects (Wallaby)
NCT06455826
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
6
Enrollment
INDUSTRY
Sponsor class
Conditions
Retinitis Pigmentosa 11
Retinal Degeneration
Eye Diseases
Retinal Disease
Retinal Dystrophies
Interventions
DRUG:
VP-001
Sponsor
PYC Therapeutics